Medical Cannabis Costs Falling: What UK Patients Need to Know

The cost of medical cannabis prescriptions in the UK has fallen considerably, with average monthly medication costs dropping by as much as 30% compared to prices seen when the market first opened. For patients, this represents a meaningful improvement in affordability and access.

How Costs Have Changed

When the UK medical cannabis market first became active following rescheduling, many patients faced monthly medication costs of three to six hundred pounds or more, depending on product type and prescribed dose. Increased market competition, improved supply chains, and a broader range of approved products have collectively driven prices down.

• Average monthly flower prescription costs now typically range from one hundred and fifty to three hundred and fifty pounds
• CBD-dominant oils have seen some of the steepest price reductions
• Competition between clinic operators has also lowered consultation fees
• Some clinics now offer fixed-price subscription models for ongoing patients

Why Costs Are Falling

More licensed producers are supplying the UK market, including operations in Portugal, Germany, and increasingly domestic UK cultivators. Greater volume and improved logistics have reduced import costs, and prescribers now have more flexibility in selecting cost-effective formulations for their patients. Patient advocacy groups have long pushed for cost reductions, arguing that price has been a significant barrier for many who could benefit from medical cannabis.

Patients looking to manage their medication costs should discuss generic or equivalent product options with their prescriber. You can compare available products through our strain directory. For a full list of clinics with transparent pricing, visit our clinic directory. Our prescription guide includes tips on navigating the consultation process efficiently.